Oric Pharmaceuticals expands 2022 inducement equity plan share pool by 1,100,000 shares

PUBT · 1d ago
Oric Pharmaceuticals expands 2022 inducement equity plan share pool by 1,100,000 shares
  • Oric Pharmaceuticals adopted an amended and restated 2022 Inducement Equity Incentive Plan effective July 28, 2026.
  • The change lifts shares reserved for issuance under the plan by 1,100,000 to 3,350,000 common shares.
  • The plan supports equity awards for new hires or eligible merger or acquisition-related grants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-326309), on July 30, 2026, and is solely responsible for the information contained therein.